Standing ballistocardiography measurements in microgravity

: The performance and practicality of a scale-based ballistocardiogram (BCG) system for hemodynamic monitoring of astronauts on extended space missions was demonstrated. The system consists of a modified electronic weighing scale fitted with foot bindings to mechanically couple the subject to the scale. This system was tested on a recent series of parabolic flights in which scale-based and accelerometry-based free-floating BCG of 10 subjects was measured in microgravity. The signal-to-noise ratio (SNR) of the scale-based BCG was, on average, a factor of 2.1 (6.3 dB) higher than the free-floating method, suggesting that the tethered scale approach might be more robust in terms of signal quality. Additionally, this approach enables practical BCG-based hemodynamic monitoring in fractional-g environments, and on small space vehicles such as NASA's upcoming Orion capsule. The scale-based results in microgravity were also compared to ground measurements (1 g), where there was an average 38.7 ms RJ interval reduction from ground to microgravity environments that is consistent across 9 of 10 subjects. This phenomenon is likely due to the transient increase in venous return, and consequent decrease in pre-ejection period, experienced during the microgravity time intervals.